Addition of apatorsen, an inhibitor of Hsp27, to first-line gemcitabine/carboplatin in advanced squamous cell lung cancer: Design of the Cedar study.
2015 ◽
Vol 33
(15_suppl)
◽
pp. TPS8111-TPS8111
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 7
(S3)
◽
pp. S198-S201
◽
Keyword(s):
2018 ◽
Vol 14
(8)
◽
pp. 765-772
◽
Keyword(s):